WallStreetZenWallStreetZen

NASDAQ: RZLT
Rezolute Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RZLT

Based on 3 analysts offering 12 month price targets for Rezolute Inc

Min Forecast
$9.00+208.22%
Avg Forecast
$11.67+299.55%
Max Forecast
$14.00+379.45%

Should I buy or sell RZLT stock?

Based on 3 analysts offering ratings for Rezolute Inc.

Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RZLT's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates RZLT as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their RZLT stock forecasts and price targets.

RZLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-02-13
lockedlocked$00.00+00.00%2025-02-13
lockedlocked$00.00+00.00%2024-11-05

1 of 1

Forecast return on equity

Is RZLT forecast to generate an efficient return?

Company
-23.71%
Industry
155.8%
Market
88.22%
RZLT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RZLT forecast to generate an efficient return on assets?

Company
-21.08%
Industry
32.81%
RZLT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RZLT earnings per share forecast

What is RZLT's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.93
Avg 2 year Forecast
-$1.15
Avg 3 year Forecast
-$1.07

RZLT revenue forecast

What is RZLT's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$3.1M
Avg 2 year Forecast
$23.8M
Avg 3 year Forecast
$108.6M

RZLT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RZLT$2.92$11.67+299.55%Buy
GNFT$3.55$13.00+266.20%Buy
DMAC$4.14$10.00+141.55%Buy
LYEL$0.59$1.00+68.35%Sell
NMRA$1.10$8.50+672.73%Buy
View Top Biotech Stocks

Rezolute Stock Forecast FAQ

Is Rezolute Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: RZLT) stock is to Buy RZLT stock.

Out of 3 analysts, 0 (0%) are recommending RZLT as a Strong Buy, 3 (100%) are recommending RZLT as a Buy, 0 (0%) are recommending RZLT as a Hold, 0 (0%) are recommending RZLT as a Sell, and 0 (0%) are recommending RZLT as a Strong Sell.

If you're new to stock investing, here's how to buy Rezolute stock.

What is RZLT's earnings growth forecast for 2025-2027?

(NASDAQ: RZLT) Rezolute's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.78%.

Rezolute's earnings in 2025 is -$71,134,000.On average, 4 Wall Street analysts forecast RZLT's earnings for 2025 to be -$56,297,945, with the lowest RZLT earnings forecast at -$58,719,362, and the highest RZLT earnings forecast at -$52,665,820. On average, 3 Wall Street analysts forecast RZLT's earnings for 2026 to be -$69,415,972, with the lowest RZLT earnings forecast at -$86,565,658, and the highest RZLT earnings forecast at -$50,849,757.

In 2027, RZLT is forecast to generate -$64,772,905 in earnings, with the lowest earnings forecast at -$78,090,698 and the highest earnings forecast at -$43,585,506.

What is RZLT's revenue growth forecast for 2026-2028?

(NASDAQ: RZLT) Rezolute's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.

Rezolute's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast RZLT's revenue for 2026 to be $187,659,818, with the lowest RZLT revenue forecast at $187,659,818, and the highest RZLT revenue forecast at $187,659,818. On average, 3 Wall Street analysts forecast RZLT's revenue for 2027 to be $1,441,953,824, with the lowest RZLT revenue forecast at $229,429,261, and the highest RZLT revenue forecast at $2,285,212,294.

In 2028, RZLT is forecast to generate $6,574,934,116 in revenue, with the lowest revenue forecast at $3,339,134,043 and the highest revenue forecast at $10,011,348,587.

What is RZLT's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: RZLT) forecast ROA is -21.08%, which is lower than the forecast US Biotechnology industry average of 32.81%.

What is RZLT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year RZLT price target, the average RZLT price target is $11.67, with the highest RZLT stock price forecast at $14.00 and the lowest RZLT stock price forecast at $9.00.

On average, Wall Street analysts predict that Rezolute's share price could reach $11.67 by Feb 13, 2026. The average Rezolute stock price prediction forecasts a potential upside of 299.55% from the current RZLT share price of $2.92.

What is RZLT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: RZLT) Rezolute's current Earnings Per Share (EPS) is -$1.22. On average, analysts forecast that RZLT's EPS will be -$0.93 for 2025, with the lowest EPS forecast at -$0.97, and the highest EPS forecast at -$0.87. On average, analysts forecast that RZLT's EPS will be -$1.15 for 2026, with the lowest EPS forecast at -$1.43, and the highest EPS forecast at -$0.84. In 2027, RZLT's EPS is forecast to hit -$1.07 (min: -$1.29, max: -$0.72).

What is RZLT's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: RZLT) forecast ROE is -23.71%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.